Cross-fund · 5 holders
KALV
KALVISTA PHARMACEUTICALS INC
CUSIP 483497103
5
Tracked holders
$201.9M
Aggregate value
10,523,429
Shares
5
Active funds
Funds holding KALV
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $76.4M | — | +41,749 | +1.1% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $43.0M | 0.06% | -146,826 | -6.4% |
| Vanguard | Institutional | Q4 2025 | $40.5M | — | +7,901 | +0.3% |
| Millennium | Multi-Strategy | Q1 2026 | $38.5M | 0.02% | -1,008,020 | -34.5% |
| Citadel | Multi-Strategy | Q1 2026 | $3.4M | — | +103,665 | +157.6% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.